World Cancer Diagnostic Testing Market 2014: Country Segment Forecasts, Market Shares, Emerging Technologies, Competitive Strategies, Growth Opportunities

Complete report $32,500.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.

This new report from Venture Planning Group contains 1,200 pages, 450 tables and provides forecasts for 40 tumor markers by country and market segment, as well as sales and market shares for reagent and instrument suppliers. 

The report is available by region, country, section, market segment and individual test:

 

Regions: Global, Europe

 

Countries: France, Germany, Italy, Japan, Spain, UK, USA

 

Sections: Assays, Competitors, Instrumentation, Technologies

 

Market Segments: Hospitals (France, Germany, Italy, Japan, Spain, UK, USA), Personalized Testing

 

Tests: AFP, Beta-2 Microglobulin, CA Tumor Markers, CEA, Cell Surface Markers, Occult Blood, PAP, Pap Smear/HPV, PSA